Original Query: ALL
Previous Study | Return to List | Next Study

Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00627588
Recruitment Status : Completed
First Posted : March 3, 2008
Last Update Posted : May 13, 2013
Information provided by (Responsible Party):
Oxford BioMedica